MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$88,879K
Investments in marketable
securities
$83,246K
Trade receivables,
net
$17,815K
Prepaid manufacturing
$6,758K
Other prepaids and
current assets
$6,233K
Inventory
$3,172K
Tsa receivables,
net
$603K
Total current assets
$206,706K
Intangible assets, net
$46,239K
Other assets,
non-current
$4,053K
Property and equipment,
net
$1,345K
Total assets
$258,343K
Total liabilities and
stockholders' equity...
$258,343K
Total liabilities
$197,329K
Total stockholders'
equity (deficit)
$61,014K
Accumulated deficit
-$1,382,969K
Accumulated other
comprehensive loss
-$195K
Total current
liabilities
$140,386K
Term loan,
non-current
$37,051K
Other liabilities,
non-current
$18,435K
Lease liabilities,
non-current
$1,457K
Additional paid-in capital
$1,444,166K
Common stock (0.0001
par value shares...
$12K
Tsa payables and
accrued liabilities
$65,065K
Accrued rebates, fees
and reserves
$30,397K
Accrued and other
current liabilities
$20,430K
Accrued compensation
$14,579K
Accounts payable
$9,915K
Back
Back
Balance Sheet
source: myfinsight.com
Coherus Oncology, Inc. (CHRS)
Coherus Oncology, Inc. (CHRS)